brightspring health services inc - BTSG

BTSG

Close Chg Chg %
37.73 0.02 0.05%

Closed Market

37.75

+0.02 (0.05%)

Volume: 894.68K

Last Updated:

Dec 26, 2025, 4:00 PM EDT

Company Overview: brightspring health services inc - BTSG

BTSG Key Data

Open

$37.86

Day Range

37.61 - 38.11

52 Week Range

15.26 - 38.42

Market Cap

$6.80B

Shares Outstanding

180.35M

Public Float

114.60M

Beta

2.38

Rev. Per Employee

N/A

P/E Ratio

62.99

EPS

$0.64

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.91M

 

BTSG Performance

1 Week
 
0.69%
 
1 Month
 
4.40%
 
3 Months
 
37.82%
 
1 Year
 
121.80%
 
5 Years
 
N/A
 

BTSG Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 17
Full Ratings ➔

About brightspring health services inc - BTSG

BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. It operates under the Pharmacy Solutions and Provider Services segments. The Pharmacy Solutions segment includes infusion and specialty pharmacy, and home and community pharmacy. The Provider Services segment is involved in home health care and community and rehab care. The company was founded in 1974 and is headquartered in Louisville, KY.

BTSG At a Glance

BrightSpring Health Services, Inc.
805 North Whittington Parkway
Louisville, Kentucky 40222
Phone 1-502-394-2100 Revenue 11.27B
Industry Medical/Nursing Services Net Income -18,062,000.00
Sector Health Services 2024 Sales Growth 27.648%
Fiscal Year-end 12 / 2025 Employees 600
View SEC Filings

BTSG Valuation

P/E Current 62.988
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.263
Price to Book Ratio 1.801
Price to Cash Flow Ratio 124.82
Enterprise Value to EBITDA 11.419
Enterprise Value to Sales 0.516
Total Debt to Enterprise Value 0.50

BTSG Efficiency

Revenue/Employee 18,777,453.333
Income Per Employee -30,103.333
Receivables Turnover 9.805
Total Asset Turnover 1.879

BTSG Liquidity

Current Ratio 1.325
Quick Ratio 0.877
Cash Ratio 0.043

BTSG Profitability

Gross Margin 14.099
Operating Margin 2.705
Pretax Margin -0.308
Net Margin -0.16
Return on Assets -0.301
Return on Equity -1.618
Return on Total Capital -0.397
Return on Invested Capital -0.422

BTSG Capital Structure

Total Debt to Total Equity 176.288
Total Debt to Total Capital 63.806
Total Debt to Total Assets 46.868
Long-Term Debt to Equity 168.368
Long-Term Debt to Total Capital 60.939
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Brightspring Health Services Inc - BTSG

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
6.70B 7.72B 8.83B 11.27B
Sales Growth
+20.03% +15.27% +14.32% +27.65%
Cost of Goods Sold (COGS) incl D&A
5.45B 6.37B 7.39B 9.68B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
199.16M 203.97M 202.34M 204.48M
Depreciation
66.70M 77.50M 79.20M 89.70M
Amortization of Intangibles
132.46M 126.47M 123.14M 114.78M
COGS Growth
+20.26% +16.82% +16.12% +30.92%
Gross Income
1.25B 1.35B 1.43B 1.59B
Gross Income Growth
+19.02% +8.49% +5.87% +10.79%
Gross Profit Margin
+18.64% +17.54% +16.24% +14.10%
2021 2022 2023 2024 5-year trend
SG&A Expense
979.96M 1.06B 1.24B 1.28B
Research & Development
- - - -
-
Other SG&A
979.96M 1.06B 1.24B 1.28B
SGA Growth
+26.46% +7.99% +17.56% +3.19%
Other Operating Expense
- - - -
-
Unusual Expense
34.07M 108.20M 42.58M 111.11M
EBIT after Unusual Expense
234.18M 187.83M 147.18M 193.65M
Non Operating Income/Expense
- - - -
-
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
165.32M 233.58M 324.59M 228.39M
Interest Expense Growth
+18.98% +41.29% +38.96% -29.64%
Gross Interest Expense
165.32M 233.58M 324.59M 228.39M
Interest Capitalized
- - - -
-
Pretax Income
68.86M (45.75M) (177.41M) (34.74M)
Pretax Income Growth
+162.45% -166.44% -287.75% +80.42%
Pretax Margin
+1.03% -0.59% -2.01% -0.31%
Income Tax
17.60M 8.46M (20.58M) (14.22M)
Income Tax - Current - Domestic
10.93M 36.38M 32.01M 16.94M
Income Tax - Current - Foreign
185.00K 43.00K 40.00K 50.00K
Income Tax - Deferred - Domestic
6.49M (27.96M) (52.63M) (31.21M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
51.26M (54.22M) (156.84M) (20.52M)
Minority Interest Expense
1.46M (312.00K) (2.23M) (2.46M)
Net Income
49.80M (53.91M) (154.60M) (18.06M)
Net Income Growth
+139.30% -208.25% -186.80% +88.32%
Net Margin Growth
+0.74% -0.70% -1.75% -0.16%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
49.80M (53.91M) (154.60M) (18.06M)
Preferred Dividends
- - - -
-
Net Income Available to Common
49.80M (53.91M) (154.60M) (18.06M)
EPS (Basic)
0.2909 -0.3149 -0.9031 -0.1037
EPS (Basic) Growth
-89.57% -208.25% -186.79% +88.52%
Basic Shares Outstanding
171.19M 171.19M 171.19M 174.25M
EPS (Diluted)
0.2909 -0.3149 -0.9031 -0.1037
EPS (Diluted) Growth
-89.54% -208.25% -186.79% +88.52%
Diluted Shares Outstanding
171.19M 171.19M 171.19M 174.25M
EBITDA
467.41M 500.00M 392.10M 509.24M
EBITDA Growth
+2.66% +6.97% -21.58% +29.88%
EBITDA Margin
+6.98% +6.48% +4.44% +4.52%

Snapshot

Average Recommendation BUY Average Target Price 41.333
Number of Ratings 17 Current Quarters Estimate 0.345
FY Report Date 12 / 2025 Current Year's Estimate 1.048
Last Quarter’s Earnings 0.30 Median PE on CY Estimate N/A
Year Ago Earnings 0.56 Next Fiscal Year Estimate 1.33
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 14 9 13 15
Mean Estimate 0.34 0.25 1.05 1.33
High Estimates 0.43 0.30 1.14 1.70
Low Estimate 0.26 0.20 0.97 1.04
Coefficient of Variance 13.13 13.36 4.16 13.23

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 16 13 12
OVERWEIGHT 0 0 0
HOLD 1 2 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Brightspring Health Services Inc - BTSG

Date Name Shares Transaction Value
Jul 31, 2025 Jon B. Rousseau See Remarks; Director 1,131,930 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $20.53 per share 23,238,522.90
Jul 30, 2025 Scott Greenwell President, PharMerica 16,839 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 30, 2025 Scott Greenwell President, PharMerica 35,920 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Jon B. Rousseau See Remarks; Director 733,496 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Lisa Nalley See Remarks 131,150 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Lisa Nalley See Remarks 97,800 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Jennifer Phipps Chief Accounting Officer 230,030 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Jennifer Phipps Chief Accounting Officer 183,374 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Jennifer Yowler President, PharMerica 75,401 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Jennifer Yowler President, PharMerica 48,900 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Walgreens Boots Alliance, Inc. 11,239,996 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $21.16 per share 237,838,315.36

Brightspring Health Services Inc in the News